09.11.2020
М. И. Каледа; И. П. Никишина; Е. С. Федоров; Е. Л. Насонов
The clinical presentation and outcomes of infection with the novel coronavirus (COVID-19
26.10.2020
Е. Л. Насонов
The coronavirus disease 2019 (COVID-19) pandemic has drawn attention to new clinical
03.09.2020
Е. Л. Насонов; Т. В. Бекетова; Т. М. Решетняк; А. М. Лила; Л. П. Ананьева; Т. А. Лисицина; С. К. Соловьев
, caused by SARS-Cov-2 (severe acute respiratory syndrome Coronavirus-2). COVID-19 is considered currently
24.06.2020
А. Е. Каратеев; Е. Л. Насонов; А. М. Лила
-steroidal anti-inflammatory drugs (NSAIDs), and in particular ibuprofen, for COVID-19 infection
23.06.2020
Е. Л. Насонов
The Coronavirus Disease 2019 (COVID-19) pandemic has drawn closer attention than ever before
15.05.2020
Е. Л. Насонов
Пандемия коронавирусной болезни 2019 (COVID-19) привлекла более пристальное, чем прежде, внимание к
24.04.2020
Е. Л. Насонов
disease (COVID-19) for this disease, whereas the International Committee on Virus Taxonomy renamed 2019
30.03.2020
Е. Л. Насонов
respiratory syndrome Coronavirus-2). Развитие пандемии COVID-19 имеет не только огромное социальное значение
23.03.2020
А. Е. Каратеев; Е. Л. Насонов; А. М. Лила
-steroidal anti-inflammatory drugs (NSAIDs), and in particular ibuprofen, for COVID-19 infection
